A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator
Clinical trial NCT04525599 · COMPLETED
Trial details
- NCT number
- NCT04525599
- Sponsor
- Affinivax, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2022-04-06
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.